During the past decade, Klinische Forschung Berlin-Buch GmbH conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 7 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinische Forschung Berlin-Buch GmbH" #1 sponsor was "Pfizer" with 6 trials, followed by "Amgen" with 2 trials sponsored, "Gilead Sciences" with 1 trials sponsored, "Shire" with 1 trials sponsored and "Wyeth is now a wholly owned subsidiary of Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Klinische Forschung Berlin-Buch GmbH" are "Psoriatic Arthritis" (3 trials), "Osteoarthritis" (2 trials), "Psoriasis" (2 trials), "Binge Eating Disorder" (1 trials) and "Hypertension" (1 trials). Many other conditions were trialed in "Klinische Forschung Berlin-Buch GmbH" in a lesser frequency.

Most popular intervention types in "Klinische Forschung Berlin-Buch GmbH" are "Drug" (11 trials), "Other" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "placebo" (2 trials), "Apremilast" (1 trials), "Apremilast 20mg" (1 trials) and "Apremilast 30mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinische Forschung Berlin-Buch GmbH" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Klinische Forschung Berlin-Buch GmbH". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Klinische Forschung Berlin-Buch GmbH, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Klinische Forschung Berlin-Buch GmbH, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".